Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
Related Posts
Bishay R, Aldana-Bitar J, Budoff MJ. Observance of rare congenital anomaly: dual right coronary artery. Coron Artery Dis. 2024 Sep 12. doi: 10.1097/MCA.0000000000001423. Epub ahead[...]
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes[...]
Miner M, Wang C, Kaminetsky J, Khera M, Goldstein I, Carson C 3rd, Chidambaram N, King S, Dobs A. Safety, efficacy, and pharmacokinetics of oral[...]